How Much Did Stark Associates Raise?
Funding & Key Investors

Stark Associates has solidified its market position through a series of significant capital injections, culminating in a total funding accumulation of $450K. The firm recently secured a major strategic investment of $300K, marking a pivotal moment in its trajectory as a late-stage enterprise. This influx of financing underscores the company's robust operational capacity and its critical role within the global clinical research landscape.

What is Stark Associates?

Stark Associates
Business ServicesResearch & DevelopmentSoftware Testing

Stark Associates operates as a comprehensive Contract Research Organization (CRO), delivering an integrated suite of services that span the entire product development lifecycle. By providing expertise in clinical trial management, regulatory affairs, and pharmacovigilance, the firm serves a diverse clientele across the pharmaceutical, biotechnology, medical device, and consumer healthcare sectors. Beyond its core research capabilities, Stark Associates distinguishes itself through specialized IT services and strategic resourcing, effectively bridging the gap between high-level technical talent and the complex demands of the healthcare industry. This multifaceted business model allows the organization to maintain a competitive edge, ensuring that clients receive both the scientific rigor and the operational agility required to navigate modern regulatory environments.

How much funding has Stark Associates raised?

Stark Associates has raised a total of $450K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$300K

Debt (2020): $150K with participation from PPP

Debt (2021): $300K led by PPP

Key Investors in Stark Associates

PPP

Public-Private Partnership

What's next for Stark Associates?

With the successful completion of this late-stage financing round, Stark Associates is well-positioned to accelerate its expansion into emerging therapeutic markets and enhance its digital infrastructure. The strategic allocation of this capital will likely focus on scaling its pharmacovigilance capabilities and deepening its investment in proprietary IT solutions to streamline trial management. As the company continues to mature, the focus will shift toward optimizing operational efficiencies and potentially pursuing inorganic growth opportunities to consolidate its footprint in the global CRO market. By leveraging its current financial backing, Stark Associates aims to reinforce its reputation as a premier partner for life sciences companies seeking to expedite time-to-market for innovative medical products.

See full Stark Associates company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject ManagementConstruction ManagementConstructionArchitecture, Engineering & Design
Business ServicesHuman Resources Management Systems (HRMS)
Advertising NetworksBusiness Services
Business ServicesChambers of CommerceHospitality

Frequently Asked Questions Regarding Stark Associates Financial Insights

What are the most recent funding rounds that Stark Associates has completed, and what were the funding rounds?
Stark Associates has recently completed 2 funding rounds: Debt on Mar 12, 2021, Debt on May 3, 2020.
What is the total amount of funding Stark Associates has raised to date?
Stark Associates has raised a total of $450K in funding to date.
How many funding rounds has Stark Associates completed?
Stark Associates has completed 2 funding rounds.
How much funding did Stark Associates raise in its most recent funding round?
Stark Associates raised $300K in its most recent funding round.
Who are the lead investors in Stark Associates's latest funding round?
The lead investor in Stark Associates's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Stark Associates's history?
The largest funding round in Stark Associates's history was $300K.
See more information about Stark Associates